Skip to main content
Livermore
Livermore
ZHEN

Balentine LLC

SEC CIK
0001586678
Latest filing
Aug 6, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Balentine LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
10,811
Value
$518.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by Balentine LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,811$518.3K<0.1%−352−3.2%ReducedHolders
Q1 202611,163$410.2K<0.1%−393−3.4%ReducedHolders
Q4 202511,556$588.0K<0.1%−210−1.8%ReducedHolders
Q3 202511,766$652.9K<0.1%−187−1.6%ReducedHolders
Q2 202511,953$825.0K<0.1%−213−1.8%ReducedHolders
Q1 202512,166$844.8K<0.1%00.0%UnchangedHolders
Q4 202412,166$1.05M<0.1%−315−2.5%ReducedHolders
Q3 202412,481$1.49M0.1%+20.0%AddedHolders
Q2 202412,479$1.78M0.1%−70,700−85.0%ReducedHolders
Q1 202483,179$10.7M0.3%+1,875+2.3%AddedHolders
Q4 202381,304$8.41M0.3%+12,741+18.6%AddedHolders
Q3 202368,563$6.24M0.2%+661+1.0%AddedConverted for a 2-for-1 splitHolders
Q2 202333,951$5.49M0.2%+1,002+3.0%AddedHolders
Q1 202332,949$5.24M0.2%+547+1.7%AddedHolders
Q4 202232,402$4.39M0.2%+5,794+21.8%AddedHolders
Q3 202226,608$2.65M0.1%−9,371−26.0%ReducedHolders
Q2 202235,979$4.01M0.1%+10,076+38.9%AddedHolders
Q1 202225,903$2.88M0.1%+8,893+52.3%AddedHolders
Q4 202117,010$1.91M0.1%+3,580+26.7%AddedHolders
Q3 202113,430$1.29M0.1%+3,670+37.6%AddedHolders
Q2 20219,760$818.0K<0.1%+1,125+13.0%AddedHolders
Q1 20218,635$582.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.